Femara

Femara (Letrozole) is an oral medication used to treat certain types of breast cancer. It works by reducing estrogen levels in the body, which can help slow the growth of cancer cells. This medication is commonly prescribed for postmenopausal women.

Femara is primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It is often prescribed after surgery or other treatments to help prevent the cancer from returning. The medication works by inhibiting the enzyme aromatase, which is responsible for producing estrogen. This reduction in estrogen levels can slow the growth of cancer cells that rely on this hormone.

Common effects of Femara may include hot flashes, joint pain, fatigue, and hair thinning. Some users may also experience nausea, headache, or dizziness. These effects can vary in severity and duration, and not everyone will experience them. It's important to discuss any persistent or bothersome effects with a healthcare provider.

Femara should be used with caution in individuals with a history of osteoporosis or liver disease. It is important to follow the prescribed dosage and not to adjust it without consulting a healthcare provider. Regular monitoring may be recommended to assess bone health and liver function during treatment.

Femara may interact with certain medications, including estrogen-containing products, tamoxifen, and other drugs that are metabolized by the liver. It is important to inform a healthcare provider about all medications being taken to avoid potential interactions. Additionally, alcohol consumption should be moderated, as it may affect liver function.